Introduction

For dentists, the connection between facial-aesthetics knowledge and the management of temporomandibular disorders may be less obvious than its connection to cosmetic concerns, yet it is arguably more directly relevant to their scope. Botulinum toxin has recognised therapeutic applications in certain temporomandibular and orofacial conditions, and the anatomical and injectable knowledge taught in aesthetics education overlaps with the knowledge needed to understand these therapeutic uses. This article explores that intersection and, crucially, draws the distinction that Ontario dentists must keep front of mind: the difference between therapeutic and cosmetic use under the position of the Royal College of Dental Surgeons of Ontario.

Where Aesthetics Knowledge Meets TMD Care

Temporomandibular disorders and orofacial pain fall squarely within the professional interests of many dentists. The muscles of mastication, the temporomandibular joint, and the surrounding neuromuscular anatomy are central to this area of care. Much of the anatomical understanding emphasised in injectable and facial-aesthetics education, including the structure and function of facial and masticatory muscles and the behaviour of neurotoxin at the neuromuscular junction, is directly relevant to understanding how botulinum toxin may be used therapeutically for certain conditions.

This overlap means that education framed around aesthetics can also deepen a dentist's grasp of the anatomy and pharmacology underpinning therapeutic applications. Clinicians who have studied how the lower face functions, a theme connected to dental aesthetics and smile proportions, often find that the same anatomical fluency supports their reasoning about orofacial pain and muscular dysfunction.

The RCDSO Distinction: Therapeutic Versus Cosmetic

This is where precision is essential. The Royal College of Dental Surgeons of Ontario holds that Ontario dentists may use botulinum toxin and dermal fillers only within the scope of dentistry. In practice, this means intra-oral use for therapeutic or cosmetic purposes, and botulinum toxin extra-orally only for therapeutic purposes, such as the management of certain temporomandibular or orofacial conditions. Ontario dentists are not authorized to inject botulinum toxin or dermal fillers extra-orally for purely cosmetic purposes.

The therapeutic application of botulinum toxin for conditions such as certain temporomandibular disorders can therefore fall within the scope of dentistry, whereas extra-oral injection for purely cosmetic reasons does not. This distinction is not a technicality; it defines the boundary of lawful practice for Ontario dentists. A clinician may be fascinated by cosmetic technique and may study it, but studying it does not make it permissible, and a training certificate does not expand scope or confer permission to practise.

Therapeutic Use Requires More Extensive Training

The RCDSO position also recognises that extra-oral therapeutic use of botulinum toxin requires more extensive training. Therapeutic application in this context is not a casual addition to practice; it demands a deeper command of anatomy, patient selection, technique, and complication management. Clinicians interested in this area should approach it with appropriate seriousness and ensure their education is commensurate with the responsibility involved, while continuing to verify their scope with the RCDSO.

Building the Knowledge Foundation

Because therapeutic injectable use rests on the same anatomical and pharmacological foundations as aesthetics education, structured training in these fundamentals can be a valuable part of a clinician's learning, provided it is kept within the boundaries of their scope. As one example, Ziba Aesthetics Training Institute in Markham offers a botulinum toxin and dermal filler course covering neurotoxin anatomy, injection technique, and complication management, which illustrates how injectable fundamentals are taught in a structured way. Describing such a program shows how foundational injectable knowledge is organised; it does not imply that any particular dentist is eligible to apply that knowledge cosmetically, and it does not expand the scope the RCDSO defines. A training certificate is not a licence or permission to practise.

Eligibility for programs varies by program and by the reader's own regulatory college. Dentists must confirm with the RCDSO which uses of botulinum toxin fall within their scope, and must recognise that extra-oral therapeutic use requires more extensive training than foundational courses alone provide.

Practising Within the Boundaries

For dentists interested in TMD and orofacial pain, the responsible path is to build strong anatomical and pharmacological knowledge, to pursue training proportionate to the therapeutic applications they intend to offer, and to keep every application firmly within the scope the RCDSO permits. Knowledge gained from aesthetics-oriented education can support therapeutic understanding, but it never authorises cosmetic use outside the mouth. Keeping this line clear protects both patients and the clinician.

Conclusion

Facial-aesthetics and injectable knowledge intersect meaningfully with TMD and orofacial pain care, because both rest on the same understanding of facial and masticatory anatomy and of how botulinum toxin acts. For Ontario dentists, the RCDSO distinction is decisive: therapeutic botulinum toxin use for certain temporomandibular or orofacial conditions can fall within the scope of dentistry with appropriate, more extensive training, while extra-oral cosmetic injection does not. Education deepens understanding, but only the regulator defines practice. Every dentist must verify their scope with the RCDSO before applying any of this knowledge.

References

  1. Royal College of Dental Surgeons of Ontario. Guidance on the use of botulinum toxin and dermal fillers within the scope of dentistry. rcdso.org.
  2. Canadian Dental Association. Temporomandibular disorders and orofacial pain resources. cda-adc.ca.
  3. Health Canada. Authorized uses of botulinum toxin products. canada.ca.
  4. College of Physicians and Surgeons of Ontario. Policies on non-surgical and therapeutic procedures. cpso.on.ca.
  5. Peer-reviewed literature on botulinum toxin in the management of temporomandibular disorders, as summarised in orofacial pain journals.